间质性肺疾病增加COVID-19易感性及严重程度
COVID-19合并ILD患者重症比例更高(47.8% vs 12.6%),死亡更高(13.4% vs 2.8%),重症风险调整后OR 2.23(95%CI 1.24-4.01)。
要点
- ILD患者感染COVID-19的调整OR为2.02(95%CI 1.54-2.61)。
- COVID-19合并ILD者重症率47.8%,死亡率13.4%。
- ILD患者发生重症COVID-19的调整OR为2.23(95%CI 1.24-4.01)。
核心结论
- ILD患者COVID-19易感性和重症风险均显著高于无ILD者。
研究设计与样本
- 采用巢式病例对照研究比较两队列ILD比例,并在COVID-19队列中评估ILD与重症风险。
主要发现
- COVID-19队列ILD比例为0.8%,匹配队列为0.4%(p<0.001)。
- COVID-19队列患ILD的调整OR为2.02(95%CI 1.54-2.61)。
- COVID-19合并ILD者重症比例47.8%,无ILD者12.6%;死亡率分别为13.4%和2.8%(均p<0.001)。
- ILD患者重症COVID-19调整OR为2.23(95%CI 1.24-4.01)。
临床怎么用
- 对ILD患者应加强COVID-19预防和早期识别,警惕重症风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There are limited data regarding the relationship between interstitial lung disease (ILD) and the natural course of COVID-19. In this study, we investigate whether patients with ILD are more susceptible to COVID-19 than those without ILD and evaluate the impact of ILD on disease severity in patients with COVID-19. METHODS: A nationwide cohort of patients with COVID-19 (n=8070) and a 1:15 age-, sex- and residential area-matched cohort (n=121 050) were constructed between 1 January 2020 and 30 May 2020 in Korea. We performed a nested case-control study to compare the proportions of patients with ILD between the COVID-19 cohort and the matched cohort. Using the COVID-19 cohort, we also evaluated the risk of severe COVID-19 in patients with ILD versus those without ILD. RESULTS: The proportion of patients with ILD was significantly higher in the COVID-19 cohort than in the matched cohort (0.8% versus 0.4%; p<0.001). The odds of having ILD was significantly higher in the COVID-19 cohort than in the matched cohort (adjusted OR 2.02, 95% CI 1.54-2.61). Among patients in the COVID-19 cohort, patients with ILD were more likely to have severe COVID-19 than patients without ILD (47.8% versus 12.6%), including mortality (13.4% versus 2.8%) (all p<0.001). The risk of severe COVID-19 was significantly higher in patients with ILD than in those without ILD (adjusted OR 2.23, 95% CI 1.24-4.01). CONCLUSION: The risks of COVID-19 and severe presentation were significantly higher in patients with ILD than in those without ILD.
引用
- Lee H, Choi H, Yang B, et al. Interstitial lung disease increases susceptibility to and severity of COVID-19. Eur Respir J. 2021. PMID: 33888524. doi:10.1183/13993003.04125-2020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。